🩺 Professional Summary

Dr. Ambreen Zahra is a postgraduate resident in Obstetrics & Gynecology (MS Track) at King Edward Medical University / Lady Aitchison Hospital, Lahore. She is involved in clinical care across maternal health, obstetric management, and gynecological services in a high-volume tertiary care hospital setting. Her clinical interests include evidence-based women’s healthcare, pregnancy-related conditions, maternal safety, and reproductive health.

🏥 Current Clinical Practice & Residency

• Lady Aitchison Hospital / King Edward Medical University, Lahore: Actively serving as a Postgraduate Resident (MS Track) within one of South Asia’s oldest and most prestigious tertiary women’s hospitals. She manages high-volume labor wards, high-risk obstetric emergencies, and specialized gynecological clinics daily, keeping her at the absolute forefront of current maternal care guidelines.

🎓 Academic Foundation & Credentials

• MBBS Graduation: Earned her core professional medical graduation credentials with academic distinction.
• Master of Surgery (MS) in Obstetrics & Gynecology: Pursuing advanced, highly competitive postgraduate doctoral surgery tracks through King Edward Medical University (KEMU), Lahore, specializing deeply in gestational drug safety, reproductive endocrinology, and maternal immunology.

📋 Areas of Review Board Focus: Allergic Rhinitis & Gestational Safety

On AllerFree Lifestyle, Dr. Zahra utilizes her active hospital experience to analyze the direct intersection of allergic rhinitis (hay fever) and women’s reproductive timelines:

• Gestational Rhinitis & Allergy Management: Vetting evidence-based protocols for distinguishing between standard gestational rhinitis (pregnancy-induced nasal congestion) and true allergic rhinitis flare-ups in expectant mothers.
• Maternal Pharmacotherapy Vetting: Cross-checking content regarding the teratogenic safety profiles, FDA pregnancy categories, and clinical constraints of over-the-counter and prescription allergy medications (antihistamines, decongestants, and corticosteroid nasal sprays) during the first, second, and third trimesters.
• Hormonal Allergic Fluctuations: Evaluating medical guidance explaining how cyclical hormonal fluctuations (such as estrogen and progesterone shifts during menstruation, oral contraceptive use, or menopause) trigger or exacerbate respiratory and skin sensitivities.